Optimized Infliximab Induction Predicts Better Long-Term Clinical and Biomarker Outcomes Compared to Standard Induction Dosing
暂无分享,去创建一个
R. Russell | R. Hansen | K. Jacobson | S. Lawrence | M. Irvine | R. Tayler | R. Harris | V. Garrick | L. Curtis | L. Gervais | G. Scott | F. Faytrouni | E. Carrion | Gregor Scott | Benjamin Clarke | M. Riou